Previously, he served as president and chief executive officer of E-Z-EM Inc., a company focusing on oral imaging contrast agents, where he created shareholder value through a spinout of AngioDynamics, Inc., the development of new products, and the subsequent sale of E-Z-EM. Mr. Lombardo joined Advaxis from The Channel Group, where he was a Partner providing strategic advisory services to biotechnology, pharma and med-tech companies. Previously, he was chief operating officer of Bracco Diagnostics, overseeing business operations for six years.
“Tony has led successful companies, achieved aggressive milestones and driven growth at all levels,” said Daniel J. O’Connor, president and chief executive officer of Advaxis. “His leadership, knowledge and experience will be assets to Advaxis.”